Jonathan Derman
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Lung Cancer Treatments and Mutations 1
- Renal cell carcinoma treatment 1
- Prostate Cancer Diagnosis and Treatment 1
- Gallbladder and Bile Duct Disorders 1
- Co-authors
- Julien Caldéraro (3 shared papers)Cécile Charpy (3 shared papers)Florent Petitprez (2 shared papers)Catherine Sautès‐Fridman (2 shared papers)Giuliana Amaddeo (2 shared papers)Wolf H. Fridman (2 shared papers)Alexis Laurent (2 shared papers)Étienne Becht (1 shared paper)
In The Last Decade
Jonathan Derman
8 papers receiving 769 citations
Jonathan Derman's Hit Papers
Peers
Comparison fields: 5 of 28
- Hepatology 215
- Oncology 218
- Radiology, Nuclear Medicine and Imaging 39
- Immunology 27
- Pathology and Forensic Medicine 25
Countries citing papers authored by Jonathan Derman
This map shows the geographic impact of Jonathan Derman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Derman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Derman more than expected).
Fields of papers citing papers by Jonathan Derman
This network shows the impact of papers produced by Jonathan Derman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Derman. The network helps show where Jonathan Derman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Derman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma Hit paper breakdown → | 2018 | 372 |
| 2 | 2017 | 205 | |
| 3 | 2020 | 94 | |
| 4 | 2018 | 40 | |
| 5 | 2020 | 30 | |
| 6 | 2019 | 18 | |
| 7 | 2021 | 11 | |
| 8 | 2018 | 6 | |
| 9 | 2025 | 1 | |
| 10 | 2021 | 0 |
About Jonathan Derman
Jonathan Derman is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Nuclear Energy and Engineering, having authored 10 papers that have together received 777 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Lung Cancer Treatments and Mutations (1 paper), Renal cell carcinoma treatment (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper), Gallbladder and Bile Duct Disorders (1 paper), Genetic factors in colorectal cancer (1 paper) and Laser Applications in Dentistry and Medicine (1 paper). The work is most often cited by research in Hepatology (215 citations), Oncology (218 citations), Radiology, Nuclear Medicine and Imaging (39 citations), Immunology (27 citations) and Pathology and Forensic Medicine (25 citations). Jonathan Derman has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Julien Caldéraro, Cécile Charpy, Florent Petitprez, Catherine Sautès‐Fridman, Giuliana Amaddeo, Wolf H. Fridman, Alexis Laurent, Étienne Becht, Jessica Zucman‐Rossi and Alain Luciani. Their work appears in journals such as Journal of Hepatology, Journal of Endourology, Clinical Cancer Research, Genes Chromosomes and Cancer and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.